|
1,6:5,9:8,12:11,16- tetraanhydro- 2,3,4,10,13,14- hexadeoxy- D- glycero- D- allo- D- gulo- heptadeca- 2,13- dienitol |
|
CHEBI:59525 |
|
1,6:5,9:8,12:11,16- tetraanhydro- 2,3,4,10,13,14- hexadeoxy- D- glycero- D- allo- D- gulo- heptadeca- 2,13- dienitol |
|
A trans-fused organic heterotetracyclic compound consisting of two fused pyran rings flanked by two oxepan rings. |
|
![](images/goldenstar.gif) ![](images/goldenstar.gif)
This entity has been manually annotated by the ChEBI Team.
|
|
|
|
Molfile
XML
SDF
|
|
|
|
InChI=1S/C17H24O7/c18- 8- 14- 9(19) 4- 5- 10- 12(23- 14) 7- 13- 17(24- 10) 15(20) 16- 11(22- 13) 3- 1- 2- 6- 21- 16/h1- 2,4- 5,9- 20H,3,6- 8H2/t9- ,10+,11- ,12- ,13+,14+,15+,16- ,17+/m0/s1 |
VJZKPEAYONAPBB-MRBBLFKKSA-N |
[H] [C@] 12C[C@@] 3([H] ) O[C@@] 4([H] ) CC=CCO[C@] 4([H] ) [C@@H] (O) [C@] 3([H] ) O[C@] 1([H] ) C=C[C@H] (O) [C@@H] (CO) O2 |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
(via 1,6:5,9:8,12:11,16-tetraanhydro-2,3,4,10,13,14-hexadeoxy-D-glycero-D-allo-D-gulo-heptadeca-2,13-dienitol )
|
|
View more via ChEBI Ontology
Outgoing
|
1,6:5,9:8,12:11,16- tetraanhydro- 2,3,4,10,13,14- hexadeoxy- D- glycero- D- allo- D- gulo- heptadeca- 2,13- dienitol
(CHEBI:59525)
has role
epitope
(CHEBI:53000)
1,6:5,9:8,12:11,16- tetraanhydro- 2,3,4,10,13,14- hexadeoxy- D- glycero- D- allo- D- gulo- heptadeca- 2,13- dienitol
(CHEBI:59525)
is a
organic heterotetracyclic compound
(CHEBI:38163)
1,6:5,9:8,12:11,16- tetraanhydro- 2,3,4,10,13,14- hexadeoxy- D- glycero- D- allo- D- gulo- heptadeca- 2,13- dienitol
(CHEBI:59525)
is a
polycyclic ether
(CHEBI:36468)
|
|
1,6:5,9:8,12:11,16- tetraanhydro- 2,3,4,10,13,14- hexadeoxy- D- glycero- D- allo- D- gulo- heptadeca- 2,13- dienitol
|
9432375
|
Reaxys Registry Number
|
Reaxys
|
12812503
|
PubMed citation
|
Europe PMC
|
18463096
|
PubMed citation
|
Europe PMC
|
19523973
|
PubMed citation
|
Europe PMC
|
|